RNXT: Marton Laurence discloses securities transactions
By AlphaYouPublished Form 4
Marton Laurence
Reporting filer
Marton Laurence reported Grant or award in RenovoRx, Inc.: 55924 units of Stock Options (right to buy) (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 2, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) (derivative) | Marton Laurence | 2026-10-01 | A | Grant or award | 55924 | 0 | 55,924 | 1 day | Filed terms
|
Stock Options (right to buy) (derivative)
- Owner
- Marton Laurence
- Date
- 2026-10-01
- Code
- A
- Action
- Grant or award
- Quantity
- 55924
- Price
- 0
- Following holdings
- 55,924
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Stock Options (right to buy)
- conversion Or Exercise Price: 1.55
- transaction Date: 2026-10-01
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 55924
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-10-01
- underlying Security Title: Common Stock
- underlying Security Shares: 55924
- shares Owned Following Transaction: 55924
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Marton Laurence: Director.
- F1: The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.